Summary
- Current Price
- As of today, FATE price is $1.50, up +1.35% on
- Current Price All-Time High
- FATE price is currently -98.76% below its historical high of $121.16 set on
- Market Cap
- FATE current market cap is $173M, up +34.81% over the past 365 days
- PE Ratio
- FATE PE ratio is unknown
- Revenue
- FATE current annual revenue is $6.65M, down -51.24% year-over-year
- Next Earnings
- The next earnings release for FATE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Fate Therapeutics, Inc. |
| Ticker | NASDAQ: FATE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fatetherapeutics.com |
| Employees | 181 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.50 | ||
| Price, 1D Change | +1.35% | |
| $173M | ||
| - | ||
| - | ||
| 0.75 | ||
| $7M | ||
| Revenue, 1Y Change | -51.24% | |
| $0.00 | ||
| EPS, 1Y Change | +100.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | -$1.01 |
| EPS Est. Change | N/A | - |
| $6.65M | ||
| Revenue Estimate | N/A | $5.14M |
| Revenue Est. Change | N/A | -22.73% |
| $1.50 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +233.33% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.59 | -$1.64 | -2.93% | |
| -$1.14 | $0.00 | +100.00% | |
| -$1.01 | N/A | - | |
| -$1.09 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $13.60M | $13.63M | +0.22% | |
| $6.46M | $6.65M | +2.85% | |
| $5.14M | N/A | -22.73% | |
| $6.75M | N/A | +1.62% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +33.93% | ||
| -75.37% | ||
| +34.81% | ||
| -71.06% | ||
| -51.24% | ||
| -93.10% | ||
| +100.00% | ||
| +100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.50 | ||
| $1.17 | ||
| SMA 200 vs Price | -21.77% | |
| $1.18 | ||
| SMA 50 vs Price | -21.41% | |
| 0.75 | ||
| $0.12 | ||
| 61.54 | ||
| 81.69% | ||
| 98.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $6.65M | ||
| $0.00 | ||
| $0.00 | ||
| -94.12% | ||
| -$147.70M | ||
| -2,222.45% | ||
| -$136.32M | ||
| -2,051.08% | ||
| -$134.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.38 | ||
| 5.79 | ||
| 5.79 | ||
| - | ||
| 3 | ||
| -5.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 26.03 | ||
| 0.84 | ||
| -0.35 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $207.18M | ||
| $203.66M | ||
| $318.94M | ||
| $208.70M | ||
| $111.75M | ||
| $36.07M | ||
| $77.85M | ||
| $4.56M | ||
| $2.66M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $142.96M | ||
| $141.45M | ||
| $12.90M | ||
| $46.52M | ||
| $12.90M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$106.08M | ||
| $111.17M | ||
| $5.49M | ||
| $5.95M | ||
| -$112.04M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| Needham | → | |
| Wells Fargo | → | |
| Needham | → | |
| Needham | → | |
| Barclays | → | |
| Baird | → | |
| Wells Fargo | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with FATE
FAQ
What is the ticker symbol for Fate Therapeutics, Inc.?
The ticker symbol for Fate Therapeutics, Inc. is NASDAQ:FATE
Does Fate Therapeutics, Inc. pay dividends?
No, Fate Therapeutics, Inc. does not pay dividends
What sector is Fate Therapeutics, Inc. in?
Fate Therapeutics, Inc. is in the Healthcare sector
What industry is Fate Therapeutics, Inc. in?
Fate Therapeutics, Inc. is in the Biotechnology industry
What country is Fate Therapeutics, Inc. based in?
Fate Therapeutics, Inc. is headquartered in United States
When did Fate Therapeutics, Inc. go public?
Fate Therapeutics, Inc. initial public offering (IPO) was on October 1, 2013
Is Fate Therapeutics, Inc. in the S&P 500?
No, Fate Therapeutics, Inc. is not included in the S&P 500 index
Is Fate Therapeutics, Inc. in the NASDAQ 100?
No, Fate Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Fate Therapeutics, Inc. in the Dow Jones?
No, Fate Therapeutics, Inc. is not included in the Dow Jones index
When was Fate Therapeutics, Inc. last earnings report?
Fate Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Fate Therapeutics, Inc. report earnings?
The next expected earnings date for Fate Therapeutics, Inc. is May 12, 2026
Data Sources & References
- FATE Official Website www.fatetherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1434316/000119312526073699/0001193125-26-073699-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434316/000119312526073699/0001193125-26-073699-index.htm
- FATE Profile on Yahoo Finance finance.yahoo.com/quote/FATE
- FATE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fate